Advertisement

Ulcus-Therapie pp 254-267 | Cite as

Ranitidin

  • A. L. Blum
Conference paper
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Histaminantagonismus, vgl. S. 225

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Barbier, P.: A comparison of ranitidine and cimetidine in the treatment of gastric ulcer—Belgian multicentre study. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  2. 2.
    Barr, G.D., Gellatly, R., Paris, C.: Comparison of ranitidine and cimetidine in duodenal ulcer. Gastroenterology 80, 1104 (1981)Google Scholar
  3. 3.
    Bell, J.A., Gower, A.J., Martin, L.E., Mills, C.E.N., Smith, W.P.: Interaction of H2- receptor antagonists with drug-metabolizing enzymes. Biochem. Soc. Trans. 9, 113–114 (1981)PubMedGoogle Scholar
  4. 4.
    Bell, J.A., Carey,P.F., Dallas, F.A.A., Dixon, G.T., Martin, L.E.: Pharmacokinetics and metabolism of ranitidine in animals and man. Proceedings of symposium on “The Clinical Use of Ranitidine” London, 1981. Med. Int. (to be published)Google Scholar
  5. 5.
    Berstad, A., Kett, K., Aadland, E., Carlsen, E., Frislid, K., Saxhaug, K., Kruse-Jensen, A.: Treatment of duodenal ulcer with ranitidine, a new histamine h2-receptor antagonist. Scand. J. Gastroenterol. 15, 637–639 (1980)PubMedCrossRefGoogle Scholar
  6. 6.
    Berstad, A., Rydning, A., Kolstad, B., Frislid, K.: Reduction of postprandial gastric acidity and pepsin concentration by ranitidine and antacids in healthy volunteers. Scand. J. Gastroenterol. [Suppl.69] 16, 67–73 (1981)Google Scholar
  7. 7.
    Bertaccini, G., Coruzzi, G.: Effect of histamine H2-receptor blockers on the isolated lower oesophageal sphincter of the rat (LES). Farmaco Ed. Sci. 36/2, 129–134 (1981)Google Scholar
  8. 7a.
    Bertaccini, G., Molina, E., Bobbio, P., Foggi, E.: Ranitidine increases lower oesophageal sphincter pressure in man. Ital. J. Gastroenterol. 13, 149–150 (1981)Google Scholar
  9. 8.
    Bianchi Porro, G.: Studies of ranitidine in Italy. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  10. 9.
    Bohnet, H.G., Riley, A.J.: An investigation on the effect of oral ranitidine treatment on hypothalamic-pituary-gonadal and hypothalamic-pituitary-adrenal function in male and female volunteers. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  11. 10.
    Bonfils, S., Mignon, M., Vallot, Mayeur, S.: Use of ranitidine in the medical treatment of Zollinger- Ellison-syndrome. Scand. J. Gastroenterol. [Suppl.69] 16, 119–122 (1981)Google Scholar
  12. 11.
    Bories, P., Michel, H., Duclos, B., Beraud, J.J., Mirouze, J.: Use of ranitidine, without mental confusion, in patients with renal failure. Lancet 1980 II, 755Google Scholar
  13. 12.
    Boyd, E.J.S., Peden, N.R., Browning, M.C.K., Saunders, J.H.B., Wormsley, K.G.: Clinical and endocrine aspects of treatment with ranitidine. Scand. J. Gastroenterol. [Suppl.69] 16, 81–83 (1981)Google Scholar
  14. 13.
    Brittain, R.T., Daly, M. J.: A review of the animal pharmacology of randitidine—A new, selective histamine H2-antagonist. Scand. J. Gastroenterol. [Suppl.69] 16, 1–9 (1981)Google Scholar
  15. 14.
    Bunce, K.T., Daly, M J., Humphray, J.M., Stables, R.: H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat. Agents Actions 11, 167–170 (1981)PubMedCrossRefGoogle Scholar
  16. 15.
    Cockel, R.: Ranitidine in the long term treatment of gastric ulcers. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  17. 16.
    Daly, M.J., Humphray, J.M., Bunce, K.T., Stables, R.: The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch. Agents Actions 11, 160–164 (1981)PubMedCrossRefGoogle Scholar
  18. 17.
    Dammann, H.G., Simon, B.: The new histamine H2-receptor antagonist ranitidine. Scand. J. Gastroenterol. [Suppl.69] 16, 39–41 (1981)Google Scholar
  19. 18.
    Dammann, H.G., Kather, H., Augustin, H.J., Simon, B.: Investigation of the duration of action of ranitidine. Dtsch. Med. Wochenschr. 105, 603 (1980)PubMedCrossRefGoogle Scholar
  20. 19.
    Dammann, H.G., Simon, B., Begemann, F.: Effect of ranitidine on duodenogastric reflux and nocturnal gastric acid secretion in man. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  21. 20.
    Desechalliers, J.P., Denis, P., Galmiche, J.P., Colin, R.: Ranitidine versus cimetidine in gastro-oesophageal reflux. A study of post-prandial oesophageal pH. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  22. 21.
    Dobrilla, G., Barbara, L., Bianchi Porro, G. et al.: Placebo controlled studies with ranitidine in duodenal ulcer. Scand. J. Gastroenterol. [Suppl. 69] 16, 101–105 (1981)Google Scholar
  23. 22.
    Van Dommelen, C.K.V., Stadler, R., Boekhorst, J.C.: Comparison of ranitidine with cimetidine in the treatment of duodenal ulcer. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  24. 23.
    Domschke, W., Lux, G., Domschke, S.: Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine. Gastroenterology 79, 1267–1271 (1980)PubMedGoogle Scholar
  25. 24.
    Edwards, C.R.W., Yeo, T., Delitala, G., Al Dujaili, E.A.S., Boscaro, M., Besser, G.M.: In vitro studies on the effects of ranitidine on isolated anterior pituitary and adrenal cells. Scand. J. Gastroenterol. [Suppl.69] 16, 75–78 (1981)Google Scholar
  26. 24a.
    Enzmann, G.D., Leonard, M., Paulsen, C.A., Rogers, J.: Effect of cimetidine on pre- productive function in men. Clin. Res. 29 (1), 26 A (1981)Google Scholar
  27. b. Feeley, J., Guy, E.: Ranitidine also reduces liver blood flow. Lancet 1982 I, 169Google Scholar
  28. 25.
    De Flora, S.: Dimetidine, ranitidine, and their mutagenic nitroso derivatives. Lancet 1981 II, 993–994Google Scholar
  29. 26.
    Garg, D.C., Weidler, D.J., Baltadano, N., Esherlman, F.N.: Pharmacokinetics of ranitidine, a new histamine H2-receptor blocker. (Abstract B. 15) Clin. Pharmacol. Ther 29(2), 247–248 (1981)Google Scholar
  30. 26a.
    Gifford, L.M., Aeugle, M.E., Myerson, R.M., Tannenbaum, P.J.: Cimetidine postmarket outpatient surveillance program. J. A.M. A. 15, 1532–1535 (1980)CrossRefGoogle Scholar
  31. 27.
    Gleeson, M.H., Hurst, R.K., Cooke, W.M., Omotosho, K.: Ranitidine in the treatment of duodenal ulcer: A comparison of two dose regimens. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  32. 28.
    Gough, K.R.: Dose comparative studies in the long term treatment of duodenal ulcer. Proceedings of symposium “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  33. 29.
    Graef, K.J., Kleist, D.V., Meyer zum Bueschenfelde, K.H.: Different effects of two histamine H2-receptor antagonists on prolactin secretion in man. Acta Endocrinol. [Suppl. 234] (Copenh.) 94, 4 (1980)Google Scholar
  34. 30.
    Henry, D.A., Langman, M.J.S.: The effects of H2 receptor antagonists on hepatic drug metabolism. Scand. J. Gastroenterol. [Suppl.69] 16, 85–88 (1981)Google Scholar
  35. 31.
    Henry, D.A., MacDonald, I.A., Kitchingman, G., Bell, G.D., Langman, M.J.S.: Cimetidine and ranitidine: Comparison of effects on hepatic drug metabolism. Br. Med. J. 281, 775–777 (1980)PubMedCrossRefGoogle Scholar
  36. 32.
    Hunt, R.H., Walt, R.P., Frost, R.A. et al.: A comparison of ranitidine with Cimetidine in the maintenance treatment of duodenal ulcer. Proceedings of symposium “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  37. 33.
    Jack, D.: Pharmacology, toxicology, and specificity. Proceedings of symposium “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  38. 33a.
    Kaul, K., Dash, R.J., Sialy, R., Broor, S.L.: Acute effects of histamine Hr and H2- receptor antagonists on pituitary hormone secretion in man. Indian J. Med. Res. 71, 768–772 (1980)Google Scholar
  39. 34.
    Kett, K., Aaland, E., Berstad, A.: Inhibition of gastric secretion in man with a new H2- receptor antagonist, ranitidine, Scan. J. Gastroenterol. 15, 249–251 (1980)CrossRefGoogle Scholar
  40. 35.
    Klotz, U., Reimann, I.W.: Influence of ranitidine on the disposition of low and high clearance drugs in man. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  41. 36.
    Konturek, S.J., Obtulowicz, W., Kwiechien, N., Sito, E., Oleksy, J., Miszczuk-Jamska, B.: Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients. Dig. Dis. Sci. 25, 737–743 (1980)PubMedCrossRefGoogle Scholar
  42. 37.
    Konturek, S.J., Kwiecien, N. Obtulowicz, W., Oleksy, J.: Cytoprotective effect of ranitidine. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  43. 38.
    Konturek, S.J., Obtulowicz, W., Kwiechien, N., Kopp, B., Oleksy, J.: Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  44. 39.
    Korman, M.G., Hansky, J., Merrett, A.C., Schmidt, G.T.: Ranitidine in duodenal ulcer: Healing rate and effect of smoking. Gastroenterology 80, 1197 (1981)Google Scholar
  45. 40.
    Langman, M.J.S., Henry, D.A., Bell, G.D., Burnham, W.R., Ogilvy, A.: Cimetidine an ranitidine in duodenal ulcer. Br. Med. J. 281, 473–474 (1980)PubMedCrossRefGoogle Scholar
  46. 41.
    Langman, M.J.S., Henry, D.A., Ogilvie, A.: Ranitidine and cimetidine for duodenal ulcer. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  47. 42.
    Lee, F.I., Costello, F.T., Fielding, J.D.: Ranitidine and cimetidine in the short-term healing of duodenal ulceration. Interim report of a single-centre, single-blind study. Proceedings of symposium on „The Clinical Use of Ranitidine“, London 1981. Med. Int. (to be published )Google Scholar
  48. 43.
    Londong, W., Londong, V., Ruthe, C., Weizert, P.: Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine. Gut 22/7, 542–548 (1981)CrossRefGoogle Scholar
  49. 44.
    Louis, W.J., Mihaly, G.W., Hanson, R.G., Anderson, A., McNeil, J.J., Yeomans, N.D., Smallwood, R.A.: Pharmacokinetic and gastric secretory studies of ranitidine in man. Scand. J. Gastroenterol. [Suppl.69] 16, 11–16 (1981)Google Scholar
  50. 45.
    McFayden, M.L., Folb, P.I., Marks, I.N., Wright, J.P., Lücke, W.: The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration. Scand. J. Gastroenterol. [Suppl.69] 16, 109–113 (1981)Google Scholar
  51. 46.
    McNeil, J.J., Mihaly, G.W., Anderson, A., Marshall, A.W., Smallwood, R.A., Louis, W.J.: Pharmacokinetics of the H2-receptor antagonist ranitidine in man. Br. J. Pharmacol. 12, 411–415 (1981)Google Scholar
  52. 47.
    Merrett, A.C. et al.: Cimetidine-induced erythema annulare centrifugum: No cross-sensitivity with ranitidine. Br. Med. J.Google Scholar
  53. a. Milton-Thompson, G.J., Lightfoot N.F., Ahmet, Z., Hunt, R.H., Barnard, J., Bavin, P.M.G., Brimblecombe, R.W., Darkin, D.W., Moore, P.J., Viney, N.: Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment. Lancet 1982 I, 1091–1095Google Scholar
  54. 48.
    Morgan, A.G., McAdam, W.A.F., Pacsoo, C.: A comparison between ranitidine and caved-s in duodenal ulcer treatment. Proceedings of symposium on „The Clinical Use of Ranitidine“, London 1981. Med. Int. (1982)Google Scholar
  55. 49.
    Moshal, M.G., Spitaels, J.M., Khan, F.: A double-blind endoscopically controlled trial of ranitidine in a high incidence area. Scand. J. Gastroenterol. [Suppl.69] 16, 129–131 (1981)Google Scholar
  56. 50.
    Müller-Lissner, S.A., Sonnenberg, A., Eichenberger, P., Blum, A.L.: Ranitidine inhibits gastric acid and pepsin secretion following sham feeding. Acta Hepatogastroenterol. (Stuttg.) 27, 377–380 (1980)Google Scholar
  57. 51.
    Myren, J., Bohman, T., Osnes, M., Larssen, S.: Normal and disturbed motility pattern in the duodenum of man. The effect of 1-hyoscyamine, trimipramine and ranitidine on the maximal pressure waves. Scand. J. Gastroenterol. [Suppl.69] 16, 1–3 (1981)Google Scholar
  58. 52.
    Nelis, G.F., van de Meene, J.G.C.: Comparative effect of cimetidine and ranitidine on prolactin secretion. Postgrad. Med. J. 56, 478–480 (1980)PubMedCrossRefGoogle Scholar
  59. 52a.
    Pare, P., Levesque, D., Farley, A., Archambault, A., Thomson, A.B.R., Sherbaniuk, R.: Effect of ranitidine on healing of duodenal and gastric ulcer. Proceedings of symposium on „The Clinical Use of Ranitidine“, London 1981. Med. Int. (1982)Google Scholar
  60. 53.
    Pasquali, R., Corinaldesi, R., Melchionda, N., Capelli, M., Barbara, L.: Effet de l’administration chronique de ranitidine sur la concentration de prolactine basale et après stimulation par TRH. Gastroenterol. Clin. Biol. 5, 585–586 (1981)Google Scholar
  61. 54.
    Pearce, P., Funder, J.W.: Histamine H2-receptor antagonists: Radioreceptor assay for antiandrogenic side effects. Clin. Exp. Pharmacol. Physiol. 7, 442 (1980)Google Scholar
  62. 55.
    Peden, N.R., Saunders, J.H.B., Wormsley, K.G.: Inhibition of pentagastrin stimulated and nocturnal secretion by ranitidine. Lancet 1979 I, 690–692 (1979)Google Scholar
  63. 56.
    Peden, N.R., Boyd, E.J.S., Browning, M.C.K., Saunders, J.H.B., Wormsley, K.G.: Effects of two histamine H2-receptor blocking drugs on basal levels of gonadotropins, prolactin, testosterone and oestadiol-17 during treatment of duodenal ulcer in male patients. Acta Endocrinol. (Copenh.) 96, 564–568 (1981)PubMedGoogle Scholar
  64. 57.
    Peden, N.R., Boyd, E.J.S., Saunders, J.H.B., Wormsley, K.G.: Ranitidine in the treatment of duodenal ulceration. Scand. J. Gastroenterol. 16, 325–329 (1981)PubMedCrossRefGoogle Scholar
  65. 58.
    Poynter, D., Spurling, N.W., Sutherland, M., Harcourt, R., Gatehouse, D., Ainge, G., Cook, J.: Safety evaluation of ranitidine. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  66. 59.
    Reed, P.I., Smight, P.L.P., Haimes, K., House, F.R.: Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet 1981 II, 553–555Google Scholar
  67. 60.
    Riley, A.J., Maconochie, J.M.: Effect of histamine H2-receptor antagonists on vasopressin and basal aldosterone secretion in man. XIIIth ACTA Endocronologica Congress, Cambridge 1981 (Abstract no 316)Google Scholar
  68. 61.
    Riley, A. J., Vrowley, P., Harrison, C.: Transfer of ranitidine to biological fluids in man: Mild and semenGoogle Scholar
  69. 62.
    Robins, A.H., McFayden, M.L.: Effect of the new H2-receptor antagonist ranitidine on plasma prolactin levels in duodenal ulcer patients. J. Pharm. Pharmacol. 33, 615–616 (1981)PubMedCrossRefGoogle Scholar
  70. 63.
    Rosario-Vieira, M.da, Godinho, F., Lurdes Tavares, M.de, Pinto Correla, J.: Double- blind cross-over comparison of effects of ranitidine and cimetidine on hepatic drug metabolism on healthy volunteers. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  71. 64.
    Ryan, F.P.: A comparison of ranitidine versus placebo in the short-term treatment of gastric ulcers. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  72. 65.
    Saunders, J.H.B, et al.: Double-blind comparison of ranitidine and Cimetidine in the treatment of duodenal ulceration. Gut 21/5, A455 (1980)Google Scholar
  73. 66.
    Schiller, K.F.R.: Comparisons of ranitidine versus Cimetidine: UK data. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int.Google Scholar
  74. 67.
    Serlin, M.J., Sibeon, R.G., Breckenridge, A.M.: Lack of effect of ranitidine on warfarin action. Br. J. Clin. Pharmacol. 12, 791–794 (1981)PubMedGoogle Scholar
  75. 68.
    Sewing, K.F.R., Billian, A., Malchow, H.: Comparative study with ranitidine and Cimetidine on gastric secretion in normal volunteers. Gut 21, 750–752 (1980)PubMedCrossRefGoogle Scholar
  76. 68a.
    Sharpe, P.C., Hawkins, B.W.: Efficacy and safety of cimetidine. Long-term treatment with Cimetidine. In: Cimetidine, Proceedings of the Second International Symposium on Histamine H2-Receptor Antagonists, pp. 358–366 (1976)Google Scholar
  77. 69.
    Sheers, R., Roberts, N.: The effect of ranitidine and Cimetidine on pentagastrin and insulin stimulated gastric secretion. Scand. J. Gastroenterol. [Suppl.69] 16, 51–58 (1981)Google Scholar
  78. 70.
    Simon, B., Kather, H.: Inhibition of the pentagastrin-stimulated gastric secretion by ranitidine in man. Dtsch. Med. Wochenschr. 104, 1676–1678 (1979)PubMedCrossRefGoogle Scholar
  79. 71.
    Smith, P.M., Overview of placebo-controlled studies in the United Kingdom. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  80. 72.
    Spiro, H.M.: United States multicentre studies of ranitidine. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  81. 73.
    Stage, J.G., Frils, J., Nielson, O.V.: Ranitidine treatment of patients with post-operative recurrent ulcer. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  82. 74.
    Staiger, C. von, Simon, B., de Vries, J., Kather, H., Walter, E.: Untersuchungen zur Wirkung von Ranitidin auf den Antypyrin-Metabolismus. Z. Gastroenterol. 18, 601–604 (1980)PubMedGoogle Scholar
  83. 75.
    Takemoto, T., Okazaki, Y., Okita, K., Namiki, M., Ishikawa, M., Oshiba, S., Kurokawa, K.: Ranitidine: A pilot study in Japan. Scand. J. Gastroenterol. [Suppl. 19] 16, 125–128 (1981)Google Scholar
  84. 76.
    Takemoto, T., Okita, K., Namiki, M., Ishikawa, M., Oshiba, S.: Clinical studies of gastric ulcers in Japan. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  85. 77.
    Van Thiel, D.H., Gavales, J.S., Smith, W.I., Paul, G.: Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N. Engl. J. Med. 300, 1012–1015 (1979)PubMedCrossRefGoogle Scholar
  86. 77a.
    Vigersky, R.A., Mehlman, I., Glass, A.R., Smith, C.E.: Treatment of hirsute women with Cimetidine. New Engl. J. Med. 303, 1042 (1980)Google Scholar
  87. 78.
    Walt, R.P., Make, P.J., Rawlings, J., Hunt, R.H., Milton-Thompson, G.J., Misiewicz, J.J.: Comparison of the effects of ranitidine, Cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer. Gut 22, 49–54 (1981)PubMedCrossRefGoogle Scholar
  88. 79.
    Walt, R.P., LaBrooy, S.J., Avgerinos, A., Oehr, T., Riley, A., Misiewicz: Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and Cimetidine on male sex hormones. Scand. J. Gastroenterol. [Suppl. 69] 16, 19–24 (1981)Google Scholar
  89. 80.
    Weingart, J., Kunert, H., Ottenjann, R.: Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by h2-receptor antagonists ranitidine and Cimetidine. Scand. J. Gastroenterol. [Suppl. 69] 16, 61–64 (1981)Google Scholar
  90. 81.
    Welder, D.J., Garg, D.C., Goldstein, J., Jallad, N.S., Eshelman, F.N.: The effects of ranitidine and Cimetidine on hepatic blood flow. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  91. 82.
    Wesdorp, E., Dekker, W., Klinkenberg, E.: Evaluation of ranitidine in the treatment of reflux esophagitis. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  92. 82a.
    White, M.C., Gore, M., Jewell, D.P.: Long-term endocrine function on cimetidine. Symposium: Peptische Läsion im Lichte von Aggression und Protektion. Wien 1978Google Scholar
  93. 82b.
    Winters, S.J., Banks, J.L., Loriaux, D.L.: Cimetidine is an antiandrogen in the rat. Gastroenterology 76, 504–508 (1979)PubMedGoogle Scholar
  94. 83.
    Woodings, E.P., Dixon, G.T., Harrison, C., Carey, P., Richards, D.A.: Ranitidine - a new H2-receptor antagonist. Gut 21, 187–191 (1980)PubMedCrossRefGoogle Scholar
  95. 84.
    Wormsley, K.G., Boyd, E.D.S., Peden, N.R., Wilson, J.A.: Low dose ranitidine in the prevention of recurrence of duodenal ulcer. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  96. 85.
    Wright, J.P., Marks, I.N., Girdwood, A.H., Lücke, W.: Treatment of gastric ulcer with ranitidine in Cape Town, South Africa. Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar
  97. 86.
    Zeitoun, P.: Comparisons of ranitidine versus Cimetidine: French patients Proceedings of symposium on “The Clinical Use of Ranitidine”, London 1981. Med. Int. (to be published )Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1982

Authors and Affiliations

  • A. L. Blum

There are no affiliations available

Personalised recommendations